A cost-saving effort by NHS England to transition multiple sclerosis (MS) patients from Biogen Inc’s (NASDAQ:BIIB) Tysabri ...
Barchart on MSN6h
2 ‘Strong Buy’ Stocks Under $10 Set to Surge as Much as 331%Generally, a “Strong Buy” rating on Wall Street indicates that analysts believe the stock will appreciate and outperform the ...
Last week’s significant news was dominated by licensing deals and mergers and acquisitions. US biotech giant Biogen entered ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback